Welcome me to the forum. It’s not hugely discussed on HC but...

Welcome me to the forum. It’s not hugely discussed on HC but looking forward to another opinion.

I was impressed by the announcement given that there was no buildup. It just seemed to arrive which means the company is willing taking in the background pushing the boundaries further and further out.

The aspect I liked about this announcement and the company as that the are a multi hardware platform. Competition are tied to specific brands of mammography machine. I see this being another opportunity to circle back to those prospective customers of which this was a barrier of entry previously.

I’m looking forward to the quarterly next month. I’m hoping to see them on track to meet/exceed targets for ARR.

The big one that is waiting in the wings is the NHS trial - this could be huge!